FDA Drug Application (017364) for AQUATENSEN by MEDPOINTE PHARM HLC

Back to FDA Applications sponsored by MEDPOINTE PHARM HLC

Application Number017364
Product Number001
FormTABLET;ORAL
Dosage5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAQUATENSEN
Active IngredientMETHYCLOTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient METHYCLOTHIAZIDE8


Back to FDA Applications sponsored by MEDPOINTE PHARM HLC